Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-11 Sale |
2024-06-11 7:42 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,136 | $31.34 | $66,942 | 147,511 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-11 7:41 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
2,636 | $31.27 | $82,428 | 145,543 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 7:34 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
85,270 | $30.3 | $2,583,782 | 289,278 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-11 7:34 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,823 | $31.34 | $57,133 | 134,811 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 7:28 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,921 | $30.74 | $89,779 | 113,774 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 9:01 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
30,426 | $32.96 | $1,002,751 | 149,647 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:07 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,705 | $28.27 | $76,469 | 149,647 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:06 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
2,381 | $28.27 | $67,310 | 148,179 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:05 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
2,738 | $28.27 | $77,402 | 154,062 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:04 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,588 | $28.27 | $73,162 | 116,695 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:03 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
2,774 | $28.27 | $78,420 | 136,634 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-13 06:04 am |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
29,491 | $26.59 | $784,248 | 156,800 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-13 06:04 am |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
109,601 | $26.11 | $2,861,373 | 169,542 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 9:58 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
2,615 | $25.65 | $67,082 | 150,560 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-12 9:57 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
88,924 | $26.19 | $2,329,007 | 129,138 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-12 9:56 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
429,730 | $25.89 | $11,125,776 | 754,536 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 9:42 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,081 | $25.7 | $53,482 | 152,352 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:57 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
9,086 | $25.85 | $234,873 | 554,385 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:56 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,373 | $25.85 | $61,342 | 154,433 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:56 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
1,591 | $25.85 | $41,127 | 186,291 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:52 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
9,921 | $25.86 | $256,585 | 153,175 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:50 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
2,434 | $25.85 | $62,919 | 141,184 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:45 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,273 | $25.85 | $58,757 | 121,955 (Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 5:08 pm |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
46,534 | $30.05 | $1,398,347 | 6,545,479 (Indirect) |
View |
| 2024-03-01 Sale |
2024-03-05 5:07 pm |
Dyne Therapeutics Inc. | DYN | Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner |
46,534 | $30.05 | $1,398,347 | 2,306,079 (Indirect Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 9:38 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
100,000 | $28.96 | $2,895,519 | 1,052,995 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 9:37 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $28.46 | $811,865 | 167,878 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 9:37 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
12,740 | $28.05 | $357,296 | 133,539 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-28 7:15 pm |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
807,838 | $24.3 | $19,626,903 | 864,487 (Indirect) |
View |
| 2024-02-26 Sale |
2024-02-28 7:13 pm |
Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner |
807,838 | $24.3 | $19,626,903 | 6,562,578 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-10 Exercise |
2024-06-11 7:34 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
80,000 | $0 | 289,278 (Direct) |
View |
| 2024-06-10 Exercise |
2024-06-11 7:34 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
80,000 | $5.54 | 289,278 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Incerti Carlo Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
25,133 | $0 | 25,133 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-22 9:01 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
30,426 | $0 | 149,647 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-22 9:01 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
30,426 | $1.03 | 149,647 (Direct) |
View |
Ownership(A) |
2024-04-04 9:07 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Cox John CEO & President |
0 | $0 | 5,000 (Direct) |
View |
| 2023-07-11 Option Award |
2024-04-04 9:06 pm |
N/A 2033-07-10 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 4:24 pm |
N/A 2034-03-24 |
Dyne Therapeutics Inc. | DYN | Cox John See Remarks |
679,853 | $0 | 679,853 (Direct) |
View |
Ownership |
2024-03-27 4:13 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Cox John See Remarks |
0 | $0 | 10,000 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-13 06:04 am |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
107,825 | $0 | 169,542 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-13 06:04 am |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
107,825 | $5.54 | 169,542 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 9:57 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
86,252 | $0 | 129,138 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 9:57 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
86,252 | $5.54 | 129,138 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 9:56 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
413,343 | $0 | 754,536 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 9:56 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
413,343 | $5.54 | 754,536 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:38 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
100,000 | $0 | 1,052,995 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:38 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
100,000 | $5.54 | 1,052,995 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $0.73 | 167,878 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $0 | 167,878 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
12,740 | $0 | 133,539 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
12,740 | $1.03 | 133,539 (Direct) |
View |